Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

ROCK2 inhibition triggers the collective invasion of colorectal adenocarcinomas.

Libanje F, Raingeaud J, Luan R, Thomas Z, Zajac O, Veiga J, Marisa L, Adam J, Boige V, Malka D, Goéré D, Hall A, Soazec JY, Prall F, Gelli M, Dartigues P, Jaulin F.

EMBO J. 2019 Jul 15;38(14):e99299. doi: 10.15252/embj.201899299. Epub 2019 Jun 18.

PMID:
31304629
2.

Molecular targeted therapy of BRAF-mutant colorectal cancer.

Ducreux M, Chamseddine A, Laurent-Puig P, Smolenschi C, Hollebecque A, Dartigues P, Samallin E, Boige V, Malka D, Gelli M.

Ther Adv Med Oncol. 2019 Jun 18;11:1758835919856494. doi: 10.1177/1758835919856494. eCollection 2019. Review.

3.

Post-shingles granulomatous dermatosis related to anti-programmed cell death 1.

Assi T, Danu A, Mateus C, Robert C, Michot JM, Ibrahim T, Lazarovici J, Ghez D, Rossignol J, Dartigues P, Terroir-Cassou-Mounat M, Ribrag V.

Immunotherapy. 2019 May;11(7):591-598. doi: 10.2217/imt-2018-0169.

PMID:
30943861
4.

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.

Casasnovas RO, Bouabdallah R, Brice P, Lazarovici J, Ghesquieres H, Stamatoullas A, Dupuis J, Gac AC, Gastinne T, Joly B, Bouabdallah K, Nicolas-Virelizier E, Feugier P, Morschhauser F, Delarue R, Farhat H, Quittet P, Berriolo-Riedinger A, Tempescul A, Edeline V, Maisonneuve H, Fornecker LM, Lamy T, Delmer A, Dartigues P, Martin L, André M, Mounier N, Traverse-Glehen A, Meignan M.

Lancet Oncol. 2019 Feb;20(2):202-215. doi: 10.1016/S1470-2045(18)30784-8. Epub 2019 Jan 15.

PMID:
30658935
5.

Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry.

Vogin G, Hettal L, Vignaud JM, Dartigues P, Goere D, Ferron G, Heyd B, Bereder JM, Tuech JJ, Glehen O, de Chaisemartin C, Lherm Y, Villeneuve L, Kepenekian V, Marchal F; RENAPE Network.

Ann Surg Oncol. 2019 Mar;26(3):852-860. doi: 10.1245/s10434-018-07153-2. Epub 2019 Jan 11.

PMID:
30635798
6.

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.

Bachy E, Maurer MJ, Habermann TM, Gelas-Dore B, Maucort-Boulch D, Estell JA, Van den Neste E, Bouabdallah R, Gyan E, Feldman AL, Bargay J, Delmer A, Slager SL, Gomes da Silva M, Fitoussi O, Belada D, Maisonneuve H, Intragumtornchai T, Ansell SM, Lamy T, Dartigues P, Link BK, Seymour JF, Cerhan JR, Salles G.

Blood. 2018 Jul 5;132(1):49-58. doi: 10.1182/blood-2017-11-816405. Epub 2018 Apr 17.

7.

Model predicting the ypN0 status after good response to chemoradiotherapy in rectal cancer.

Dumont F, Dartigues P, Delga B, Thibaudeau E, Benhaim L, Campion L, Mosnier JF, Raimbourg J, Kerdraon O, Goéré D.

Am J Surg. 2018 Sep;216(3):438-443. doi: 10.1016/j.amjsurg.2018.03.025. Epub 2018 Mar 31.

PMID:
29656991
8.

Daily Biopsy Diagnosis in Surgical Pathology: Concordance Between Light Microscopy and Whole-Slide Imaging in Real-Life Conditions.

Villa I, Mathieu MC, Bosq J, Auperin A, Pomerol JF, Lacroix-Triki M, Scoazec JY, Dartigues P.

Am J Clin Pathol. 2018 Mar 7;149(4):344-351. doi: 10.1093/ajcp/aqx161.

PMID:
29452345
9.

Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas.

Zajac O, Raingeaud J, Libanje F, Lefebvre C, Sabino D, Martins I, Roy P, Benatar C, Canet-Jourdan C, Azorin P, Polrot M, Gonin P, Benbarche S, Souquere S, Pierron G, Nowak D, Bigot L, Ducreux M, Malka D, Lobry C, Scoazec JY, Eveno C, Pocard M, Perfettini JL, Elias D, Dartigues P, Goéré D, Jaulin F.

Nat Cell Biol. 2018 Mar;20(3):296-306. doi: 10.1038/s41556-017-0027-6. Epub 2018 Feb 5.

PMID:
29403038
10.

Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets.

Bolen CR, McCord R, Huet S, Frampton GM, Bourgon R, Jardin F, Dartigues P, Punnoose EA, Szafer-Glusman E, Xerri L, Sujobert P, Salles G, Venstrom JM.

Blood Adv. 2017 Sep 27;1(22):1884-1890. doi: 10.1182/bloodadvances.2016000786. eCollection 2017 Oct 10.

11.

[Hodgkin lymphoma: Current and future therapeutic strategies].

Turpin A, Michot JM, Kempf E, Mazeron R, Dartigues P, Terroir M, Boros A, Bonnetier S, Castilla-Llorente C, Coman T, Danu A, Ghez D, Pilorge S, Arfi-Rouche J, Dercle L, Soria JC, Carde P, Ribrag V, Fermé C, Lazarovici J.

Bull Cancer. 2018 Jan;105(1):81-98. doi: 10.1016/j.bulcan.2017.11.008. Epub 2017 Dec 27. Review. French.

PMID:
29289336
12.

Conversion to Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma After Bidirectional Chemotherapy.

Le Roy F, Gelli M, Hollebecque A, Honoré C, Boige V, Dartigues P, Benhaim L, Malka D, Ducreux M, Elias D, Goéré D.

Ann Surg Oncol. 2017 Nov;24(12):3640-3646. doi: 10.1245/s10434-017-6033-x. Epub 2017 Aug 28.

PMID:
28849389
13.

The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei.

Carr NJ, Bibeau F, Bradley RF, Dartigues P, Feakins RM, Geisinger KR, Gui X, Isaac S, Milione M, Misdraji J, Pai RK, Rodriguez-Justo M, Sobin LH, van Velthuysen MF, Yantiss RK.

Histopathology. 2017 Dec;71(6):847-858. doi: 10.1111/his.13324. Epub 2017 Sep 19. Review.

PMID:
28746986
14.

Gastrointestinal stromal tumors (GIST) presenting in the liver: Diagnostic, prognostic and therapeutic issues.

Joyon N, Dumortier J, Aline-Fardin A, Caramella C, Valette PJ, Blay JY, Scoazec JY, Dartigues P.

Clin Res Hepatol Gastroenterol. 2018 Apr;42(2):e23-e28. doi: 10.1016/j.clinre.2017.05.010. Epub 2017 Jun 20.

PMID:
28645742
15.

Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma.

Lazarovici J, Terroir M, Arfi-Rouche J, Michot JM, Mussot S, Florea V, Ghigna MR, Dartigues P, Petrovanu C, Danu A, Fermé C, Ribrag V, Ghez D.

Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2018-2024. doi: 10.1007/s00259-017-3758-5. Epub 2017 Jun 21.

PMID:
28634685
16.

Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study.

Valmary-Degano S, Colpart P, Villeneuve L, Monnien F, M'Hamdi L, Lang Averous G, Capovilla M, Bibeau F, Laverriere MH, Verriele-Beurrier V, Ben Rejeb H, Dartigues P, Hommell-Fontaine J, Gilly FN, Isaac S, Mery E; French RENAPE Network.

Eur J Surg Oncol. 2017 Oct;43(10):1915-1923. doi: 10.1016/j.ejso.2017.05.009. Epub 2017 May 18.

PMID:
28619621
17.

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network.

Laurent C, Baron M, Amara N, Haioun C, Dandoit M, Maynadié M, Parrens M, Vergier B, Copie-Bergman C, Fabiani B, Traverse-Glehen A, Brousse N, Copin MC, Tas P, Petrella T, Rousselet MC, Brière J, Charlotte F, Chassagne-Clement C, Rousset T, Xerri L, Moreau A, Martin A, Damotte D, Dartigues P, Soubeyran I, Peoch M, Dechelotte P, Michiels JF, de Mascarel A, Berger F, Bossard C, Arbion F, Quintin-Roué I, Picquenot JM, Patey M, Fabre B, Sevestre H, Le Naoures C, Chenard-Neu MP, Bastien C, Thiebault S, Martin L, Delage M, Filleron T, Salles G, Molina TJ, Delsol G, Brousset P, Gaulard P.

J Clin Oncol. 2017 Jun 20;35(18):2008-2017. doi: 10.1200/JCO.2016.71.2083. Epub 2017 May 1.

PMID:
28459613
18.

[Gastric adenoma of pyloric type associated with familial adenomatous polyposis: A rare histological type not to be overlooked].

Didier J, Dartigues P, Soufan R, Malka D, Burtin P, Scoazec JY.

Ann Pathol. 2017 Apr;37(2):175-181. doi: 10.1016/j.annpat.2017.01.003. Epub 2017 Mar 9. French.

PMID:
28285810
19.

Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer.

Vychnevskaia K, Dumont F, Agostini J, Julié C, Dartigues P, Lazure T, Boige V, Goéré D, Brouquet A, Penna C, Peschaud F, Benoist S.

Ann Surg Oncol. 2017 May;24(5):1304-1311. doi: 10.1245/s10434-016-5736-8. Epub 2016 Dec 22.

PMID:
28008572
20.

Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association.

Sarkozy C, Molina T, Ghesquières H, Michallet AS, Dupuis J, Damotte D, Morsschauser F, Parrens M, Martin L, Dartigues P, Stamatoullas A, Hirsch P, Fabiani B, Bouabdallah K, da Silva MG, Maerevoet M, Laurent C, Coiffier B, Salles G, Traverse-Glehen A.

Haematologica. 2017 Jan;102(1):150-159. doi: 10.3324/haematol.2016.152256. Epub 2016 Oct 6.

21.

Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei.

Delhorme JB, Honoré C, Benhaim L, Dumont F, Dartigues P, Dromain C, Ducreux M, Elias D, Goéré D.

Eur J Surg Oncol. 2017 Jan;43(1):159-167. doi: 10.1016/j.ejso.2016.08.021. Epub 2016 Sep 2.

PMID:
27646440
22.

Patent blue V and indocyanine green for fluorescence microimaging of human peritoneal carcinomatosis using probe-based confocal laser endomicroscopy.

Abbaci M, Dartigues P, De Leeuw F, Soufan R, Fabre M, Laplace-Builhé C.

Surg Endosc. 2016 Dec;30(12):5255-5265. Epub 2016 Apr 8.

PMID:
27059962
23.

Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cells.

Vacchelli E, Semeraro M, Adam J, Dartigues P, Zitvogel L, Kroemer G.

Oncoimmunology. 2015 Jul 1;5(2):e1064581. eCollection 2016 Feb.

24.

Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.

Bachy E, Estell JA, Van de Neste E, Bouabdallah R, Bargay J, Delmer A, Gelas-Dore B, Gomes da Silva M, Fitoussi O, Belada D, Maisonneuve H, Intragumtornchai T, Lamy T, Dartigues P, Seymour JF, Salles G.

Am J Hematol. 2016 Jun;91(4):410-5. doi: 10.1002/ajh.24305.

25.

Azathioprine May Not be Associated With Development of Colorectal Tumors With Microsatellite Instability in Patients With Inflammatory Bowel Disease.

Svrcek M, Beaugerie L, Kirchgesner J, Dumont S, Muleris M, Bodo S, Dartigues P, Lascols O, Seksik P, Cosnes J, Fléjou JF, Duval A.

Am J Gastroenterol. 2016 Jan;111(1):149-51. doi: 10.1038/ajg.2015.406. No abstract available.

PMID:
26785668
26.

Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study.

Lazarovici J, Dartigues P, Brice P, Obéric L, Gaillard I, Hunault-Berger M, Broussais-Guillaumot F, Gyan E, Bologna S, Nicolas-Virelizier E, Touati M, Casasnovas O, Delarue R, Orsini-Piocelle F, Stamatoullas A, Gabarre J, Fornecker LM, Gastinne T, Peyrade F, Roland V, Bachy E, André M, Mounier N, Fermé C.

Haematologica. 2015 Dec;100(12):1579-86. doi: 10.3324/haematol.2015.133025. Epub 2015 Oct 1.

27.

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy.

Vacchelli E, Semeraro M, Enot DP, Chaba K, Poirier Colame V, Dartigues P, Perier A, Villa I, Rusakiewicz S, Gronnier C, Goéré D, Mariette C, Zitvogel L, Kroemer G.

Oncotarget. 2015 Aug 28;6(25):20840-50.

28.

Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.

Michot JM, Mazeron R, Danu A, Lazarovici J, Ghez D, Antosikova A, Willekens C, Chamseddine AN, Minard V, Dartigues P, Bosq J, Carde P, Koscielny S, De Botton S, Ferme C, Girinsky T, Ribrag V.

Eur J Cancer. 2015 Nov;51(16):2386-95. doi: 10.1016/j.ejca.2015.07.009. Epub 2015 Aug 5.

PMID:
26254810
29.

Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix.

Honoré C, Caruso F, Dartigues P, Benhaim L, Chirica M, Goéré D, Elias D.

Anticancer Res. 2015 Sep;35(9):4943-7.

PMID:
26254392
30.

[Peritoneal tumor pathology - case no. 3 : peritoneal well-differentiated papillary mesothelioma].

Dartigues P.

Ann Pathol. 2015 Aug;35(4):327-37. doi: 10.1016/j.annpat.2015.06.006. Epub 2015 Jul 23. Review. French. No abstract available.

PMID:
26210689
31.

[Peritoneal tumor pathology - case no. 1: pseudomyxoma peritonei].

Dartigues P.

Ann Pathol. 2015 Aug;35(4):311-20. doi: 10.1016/j.annpat.2015.06.003. Epub 2015 Jul 22. Review. French. No abstract available.

PMID:
26210688
32.

Simple criteria to predict margin involvement after chemoradiotherapy and sphincter-sparing for low rectal cancer.

Dumont F, Tilly C, Dartigues P, Goéré D, Honoré C, Elias D.

Eur J Surg Oncol. 2015 Sep;41(9):1210-6. doi: 10.1016/j.ejso.2015.05.016. Epub 2015 Jun 19.

PMID:
26108736
33.

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.

de Leval L, Parrens M, Le Bras F, Jais JP, Fataccioli V, Martin A, Lamant L, Delarue R, Berger F, Arbion F, Bossard C, Copin MC, Canioni D, Charlotte F, Damaj G, Dartigues P, Fabiani B, Ledoux-Pilon A, Montagne K, Molina T, Patey M, Tas P, Peoch M, Petit B, Petrella T, Picquenot JM, Rousset T, Rousselet MC, Soubeyran I, Thiebault S, Tournilhac O, Xerri L, Gisselbrecht C, Haioun C, Delsol G, Gaulard P.

Haematologica. 2015 Sep;100(9):e361-4. doi: 10.3324/haematol.2015.126300. Epub 2015 Jun 4. No abstract available.

34.

Red and far-red fluorescent dyes for the characterization of head and neck cancer at the cellular level.

Abbaci M, Casiraghi O, Temam S, Ferchiou M, Bosq J, Dartigues P, De Leeuw F, Breuskin I, Laplace-Builhé C.

J Oral Pathol Med. 2015 Nov;44(10):831-41. doi: 10.1111/jop.12316. Epub 2015 Mar 16.

PMID:
25779631
35.

Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastases.

Allard MA, Sebagh M, Baillie G, Lemoine A, Dartigues P, Faitot F, Faron M, Boige V, Vitadello F, Vibert E, Elias D, Adam R, Goéré D, Sa Cunha A.

Ann Surg Oncol. 2015;22(6):1925-32. doi: 10.1245/s10434-014-4272-7. Epub 2014 Dec 2.

PMID:
25448804
36.

Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin.

Elias D, Mariani A, Cloutier AS, Blot F, Goéré D, Dumont F, Honoré C, Billard V, Dartigues P, Ducreux M.

Eur J Surg Oncol. 2014 Nov;40(11):1467-73. doi: 10.1016/j.ejso.2014.06.006. Epub 2014 Jul 3.

PMID:
25086990
37.

Liver, lung and peritoneal metastases in colorectal cancers: is the patient still curable? What should the radiologist know.

Dromain C, Caramella C, Dartigues P, Goere D, Ducreux M, Deschamps F.

Diagn Interv Imaging. 2014 May;95(5):513-23. doi: 10.1016/j.diii.2014.03.011. Epub 2014 May 1.

38.

[Peritoneal malignant mesothelioma: review and recent data].

Mery É, Hommell-Fontaine J, Capovilla M, Chevallier A, Bibeau F, Croce S, Dartigues P, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Poizat F, Robin N, Valmary-Degano S, Verriele-Beurrier V, Villeneuve L, Isaac S.

Ann Pathol. 2014 Feb;34(1):26-33. doi: 10.1016/j.annpat.2014.01.004. Epub 2014 Feb 11. Review. French.

PMID:
24630634
39.

[Peritoneal pseudomyxoma: an overview emphasizing pathological assessment and therapeutic strategies].

Dartigues P, Isaac S, Villeneuve L, Glehen O, Capovilla M, Chevallier A, Croce S, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Mery É, Poizat F, Valmary-Degano S, Verriele-Beurrier V, Gilly FN, Bibeau F.

Ann Pathol. 2014 Feb;34(1):14-25. doi: 10.1016/j.annpat.2014.01.012. Epub 2014 Feb 25. French.

PMID:
24630633
40.

[The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists].

Villeneuve L, Isaac S, Glehen O, Capovilla M, Chevallier A, Croce S, Dartigues P, Fontaine J, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Mery E, Poizat F, Valmary-Degano S, Verriele-Beurrier V, Gilly FN, Bibeau F.

Ann Pathol. 2014 Feb;34(1):4-8. doi: 10.1016/j.annpat.2014.01.008. Epub 2014 Feb 20. French.

PMID:
24630631
41.

Prognostic similarities and differences in optimally resected liver metastases and peritoneal metastases from colorectal cancers.

Elias D, Faron M, Iuga BS, Honoré C, Dumont F, Bourgain JL, Dartigues P, Ducreux M, Goéré D.

Ann Surg. 2015 Jan;261(1):157-63. doi: 10.1097/SLA.0000000000000582.

PMID:
24509197
42.

Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases.

Elias D, Goéré D, Dumont F, Honoré C, Dartigues P, Stoclin A, Malka D, Boige V, Ducreux M.

Eur J Cancer. 2014 Jan;50(2):332-40. doi: 10.1016/j.ejca.2013.09.024. Epub 2013 Oct 21. Review.

PMID:
24157254
43.

Value of cardiophrenic angle lymph node for the diagnosis of colorectal peritoneal carcinomatosis.

Caramella C, Pottier E, Borget I, Malka D, Goéré D, Boige V, Honoré C, Dartigues P, Dumont F, Ducreux M, Elias D, Dromain C.

Eur J Cancer. 2013 Dec;49(18):3798-805. doi: 10.1016/j.ejca.2013.06.044. Epub 2013 Jul 27.

PMID:
23899531
44.

Comprehensive study of ovarian metastases in young women with peritoneal pseudomyxoma: is a preservation of fertility possible?

Elias D, Duchalais E, David A, Dartigues P, Duvillard P, Poirot C, Goéré D.

Eur J Surg Oncol. 2013 Jul;39(7):748-53. doi: 10.1016/j.ejso.2013.03.005. Epub 2013 Mar 21.

PMID:
23523317
45.

A new policy regarding ovarian resection in young women treated for peritoneal carcinomatosis.

Elias D, Duchalais E, Dartigues P, Duvillard P, Poirot C, Goéré D.

Ann Surg Oncol. 2013 Jun;20(6):1837-42. doi: 10.1245/s10434-013-2879-8. Epub 2013 Feb 1.

PMID:
23370670
46.

Ovarian metastasis is associated with retroperitoneal lymph node relapses in women treated for colorectal peritoneal carcinomatosis.

Eveno C, Goéré D, Dartigues P, Honoré C, Dumont F, Tzanis D, Benhaim L, Malka D, Elias D.

Ann Surg Oncol. 2013 Feb;20(2):491-6. doi: 10.1245/s10434-012-2623-9. Epub 2012 Sep 7.

PMID:
22956066
47.

Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms.

Ghesquières H, Cartron G, Seymour JF, Delfau-Larue MH, Offner F, Soubeyran P, Perrot A, Brice P, Bouabdallah R, Sonet A, Dupuis J, Casasnovas O, Catalano JV, Delmer A, Jardin F, Verney A, Dartigues P, Salles G.

Blood. 2012 Sep 27;120(13):2650-7. Epub 2012 Aug 10.

PMID:
22885164
48.

Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.

Julien S, Merino-Trigo A, Lacroix L, Pocard M, Goéré D, Mariani P, Landron S, Bigot L, Nemati F, Dartigues P, Weiswald LB, Lantuas D, Morgand L, Pham E, Gonin P, Dangles-Marie V, Job B, Dessen P, Bruno A, Pierré A, De Thé H, Soliman H, Nunes M, Lardier G, Calvet L, Demers B, Prévost G, Vrignaud P, Roman-Roman S, Duchamp O, Berthet C.

Clin Cancer Res. 2012 Oct 1;18(19):5314-28. doi: 10.1158/1078-0432.CCR-12-0372. Epub 2012 Jul 23.

49.

Central retroperitoneal recurrences from colorectal cancer: are lymph node and locoregional recurrences the same disease?

Dumont F, Kothodinis K, Goéré D, Honoré C, Dartigues P, Boige V, Ducreux M, Malka D, Elias D.

Eur J Surg Oncol. 2012 Jul;38(7):611-6. doi: 10.1016/j.ejso.2012.04.003. Epub 2012 Apr 21.

PMID:
22525856
50.

Peritoneal carcinomatosis from solid pseudopapillary neoplasm (Frantz's tumour) of the pancreas treated with HIPEC.

Honore C, Goere D, Dartigues P, Burtin P, Dumont F, Elias D.

Anticancer Res. 2012 Mar;32(3):1069-73.

PMID:
22399634

Supplemental Content

Loading ...
Support Center